Scholar Rock Holding (SRRK) Cash from Operations (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Cash from Operations of 82101000.0 in Q1 2026, down 8.75% quarter-over-quarter from 75496000.0 in Q4 2025, and down 4.35% on a YoY basis from 85838963.64 in Q1 2025.

Scholar Rock Holding (SRRK) Cash from Operations (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Cash from Operations history runs 10 years deep, the most recent figure standing at 82101000.0 for Q1 2026.

  • In Q1 2026, Cash from Operations fell 4.35% year-over-year to 82101000.0; the TTM figure through Mar 2026 stood at 303461000.0 (down 32.03% YoY), while the FY2025 annual figure was 300035000.0, down 49.31% from the prior year.
  • Cash from Operations was 82101000.0 for Q1 2026 at Scholar Rock Holding, down from 75496000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 26483000.0 in Q3 2022 to a low of 82101000.0 in Q1 2026.
  • Historically, Cash from Operations has averaged 50647352.94 across 5 years, with a median of 49196000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2024: Cash from Operations increased 26.39% in 2022, then sank 62.54% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 28907000.0 in 2022, then slipped by 29.2% to 37349000.0 in 2023, then slumped by 32.57% to 49513000.0 in 2024, then tumbled by 52.48% to 75496000.0 in 2025, then declined by 8.75% to 82101000.0 in 2026.
  • The last three Cash from Operations figures came in at 82101000.0 (Q1 2026), 75496000.0 (Q4 2025), and 68923000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -1.67 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -12.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -2.49 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.43 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - -82.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -82.10 Mn
Mar 31, 2026 -82.10 Mn
Dec 31, 2025 -75.50 Mn
Dec 31, 2025 -75.50 Mn
Sep 30, 2025 -68.92 Mn
Sep 30, 2025 -68.92 Mn
Jun 30, 2025 -76.94 Mn
Jun 30, 2025 -76.94 Mn
Mar 31, 2025 -78.68 Mn
Mar 31, 2025 -78.68 Mn
Dec 31, 2024 -49.51 Mn
Dec 31, 2024 -49.51 Mn
Sep 30, 2024 -52.46 Mn
Sep 30, 2024 -52.46 Mn
Jun 30, 2024 -49.20 Mn
Jun 30, 2024 -49.20 Mn
Mar 31, 2024 -49.79 Mn
Mar 31, 2024 -49.79 Mn
Dec 31, 2023 -37.35 Mn
Dec 31, 2023 -37.35 Mn